Knowledge, perceptions, and use of psychedelics for mental health among autistic adults: An online survey
PLOS mental health December 26, 2025 Sahba Afsharnia, Vivian Liang, Yona Lunsky et al. 1 citation
Psychedelics such as psilocybin, LSD, and MDMA have shown promise in treating mental health conditions (e.g., depression, post-traumatic stress disorder) among neurotypical individuals, i.e., typically developing individuals without a diagnosed neurodevelopmental condition. However, their therapeutic potential for treating co-occurring mental-health conditions in autistic individuals remains...
DOI: 10.1371/journal.pmen.0000514 (opens in new tab)
Psilocybin
Anxiety
Neurotypical
Autism
+5